scispace - formally typeset
A

A López-Navidad

Researcher at Autonomous University of Barcelona

Publications -  44
Citations -  1129

A López-Navidad is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Transplantation & Organ donation. The author has an hindex of 19, co-authored 44 publications receiving 1090 citations.

Papers
More filters
Journal ArticleDOI

Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool.

TL;DR: The terms extended donor or expanded donor mean changes in donor acceptability criteria and in almost all cases, the negative connotations of these terms cannot be justified.
Journal ArticleDOI

Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers

TL;DR: Clinically prescribed sunscreen creams caused a minor decrease in 25‐hydroxyvitamin D levels, which did not induce secondary hyperparathyroidism or an increment in bone biological markers.
Journal ArticleDOI

Successful transplantation of organs retrieved from donors with bacterial meningitis

TL;DR: This study demonstrates that patients with brain death caused by bacterial meningitis due to meningococci, pneumococci or E coli may be suitable organ donors and transplantation of organs from such donors does not increase the risk of infection transmission to the recipient, provided that both donor and recipient had received adequate antibiotic therapy.
Journal ArticleDOI

Increasing Human-Organ Transplant Availability: Argumentation-Based Agent Deliberation

TL;DR: A novel organ-selection process uses a multiagent system called Carrel+ to let geographically dispersed transplant physicians deliberate over organ viability to increase the availability of organs for transplantation.
Journal Article

Early diagnosis of brain death in patients treated with central nervous system depressant drugs

TL;DR: Transcranial Doppler ultrasound and 99mTc-HMPAO brain scintigraphy can significantly reduce the time taken to confirm brain death in patients with significant serum levels of CNS depressant drugs.